First Time Loading...

Phathom Pharmaceuticals Inc
NASDAQ:PHAT

Watchlist Manager
Phathom Pharmaceuticals Inc Logo
Phathom Pharmaceuticals Inc
NASDAQ:PHAT
Watchlist
Price: 10.1 USD -1.37% Market Closed
Updated: May 9, 2024

Phathom Pharmaceuticals Inc
Cost of Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Phathom Pharmaceuticals Inc
Cost of Revenue Peer Comparison

Comparables:
JNJ
BMY
PFE
MRK
LLY

Competitive Cost of Revenue Analysis
Latest Figures & CAGR of Competitors

Company Cost of Revenue CAGR 3Y CAGR 5Y CAGR 10Y
Phathom Pharmaceuticals Inc
NASDAQ:PHAT
Cost of Revenue
-$167k
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Johnson & Johnson
NYSE:JNJ
Cost of Revenue
-$26.1B
CAGR 3-Years
3%
CAGR 5-Years
1%
CAGR 10-Years
-2%
Bristol-Myers Squibb Co
NYSE:BMY
Cost of Revenue
-$11B
CAGR 3-Years
-3%
CAGR 5-Years
-10%
CAGR 10-Years
-9%
Pfizer Inc
NYSE:PFE
Cost of Revenue
-$16.3B
CAGR 3-Years
-57%
CAGR 5-Years
N/A
CAGR 10-Years
-6%
Merck & Co Inc
NYSE:MRK
Cost of Revenue
-$15.4B
CAGR 3-Years
-5%
CAGR 5-Years
-4%
CAGR 10-Years
1%
Eli Lilly and Co
NYSE:LLY
Cost of Revenue
-$7.1B
CAGR 3-Years
-5%
CAGR 5-Years
-9%
CAGR 10-Years
-4%

See Also

What is Phathom Pharmaceuticals Inc's Cost of Revenue?
Cost of Revenue
-167k USD

Based on the financial report for Dec 31, 2023, Phathom Pharmaceuticals Inc's Cost of Revenue amounts to -167k USD.